SCHEMBL30749309

SCHEMBL30749309

CC(C)(C)OC(=O)N1CCCCC[C@@H]1c1cc(Cl)ccc1CN(C(=S)NC(=O)c1ccccc1)c1nc[nH]c1C(N)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.37
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ TSHR P16473 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ POLB P06746 3/20 0.33
▸ USP30 Q70CQ3 2/20 0.33
▸ UCHL1 P09936 1/20 0.33
▸ CPT1A P50416 2/20 0.33
▸ CPT2 P23786 1/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ ANO1 Q5XXA6 1/20 0.32
▸ CHEK2 O96017 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27231643 0.91 CPT1A (0.34) ALDH1A1MEN1KMT2ANPSR1LMNA
SCHEMBL27224146 0.91 CPT1A (0.34) ALDH1A1MEN1KMT2ANPSR1LMNA
SCHEMBL30749253 0.90 MPO (0.40) ALDH1A1MEN1KMT2ATSHRMAPT
SCHEMBL30749335 0.90 MEN1 (0.33) ALDH1A1MEN1KMT2ATSHRMAPT
SCHEMBL27223612 0.81 MDM2 (0.38) ALDH1A1MEN1KMT2ATSHRMAPT
SCHEMBL30749300 0.81 MDM2 (0.38) ALDH1A1MEN1KMT2ATSHRMAPT
SCHEMBL30749267 0.81 MPO (0.38) ALDH1A1
SCHEMBL27224080 0.80 USP2 (0.33) ALDH1A1MAPTCPT1APKMMAPK1
SCHEMBL30749331 0.80 MEN1 (0.39) ALDH1A1MEN1KMT2ATSHRMAPT
SCHEMBL27223573 0.80 MEN1 (0.39) ALDH1A1MEN1KMT2ATSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4573096-A1 INHIBITORS OF MYELOPEROXIDASE Astrazeneca AB (SE) 2025-06-25 — — EP disclosed
WO-2024038131-A1 INHIBITORS OF MYELOPEROXIDASE ASTRAZENECA AB (SE) 2024-02-22 — — WO disclosed
Send feedback